Next Gen Sequencing - The Online Scientific Community

Illumina Launches TruSight™ Tumor Content Set
Tuesday, April 09, 2013
Enables somatic variant detection in solid tumors using next-generation sequencing (NGS).

Illumina Launches TruSightTM Tumor Content Set
Thursday, April 04, 2013
Enables somatic variant detection in solid tumors using next-generation sequencing (NGS).

Life Technologies Launches Two Ion AmpliSeq™ Community Panel Designs
Wednesday, April 03, 2013
Company has launched Ion AmpliSeq™ BRCA1 and BRCA2 Panel and the Ion AmpliSeq™ Colon & Lung Cancer Panel.

RNA Sequencing Kits Improve NGS Workflow
Friday, March 22, 2013
AMSBIO’s kits shorten sample library preparation time and labour and minimize errors.

Swift Biosciences Introduces Accel-NGS™ DNA Library Kit
Thursday, February 28, 2013
Swift Biosciences, Inc. today announced the launch of the Accel-NGS™ DNA Library Kit, the first product in a new line of kits for Next Generation Sequencing (NGS) sample preparation.

Agilent Technologies Introduces SureSelect Strand-Specific RNA Library Preparation Kit
Thursday, February 21, 2013
New product designed for whole transcriptome and targeted RNA sequencing. Agilent Technologies Inc. introduced the SureSelect Strand-Specific RNA Library Preparation Kit for whole transcriptome and targeted RNA sequencing.

Agilent Technologies Launches Genomic DNA ScreenTape
Thursday, February 21, 2013
Product is prepackaged consumables device that works with the company's 2200 TapeStation instrument to determine the quantity, size and quality of genomic DNA in less than two minutes per sample, using only one microliter of material.

DNASTAR Software Releases Lasergene 10.1
Monday, February 04, 2013
New software supports automated bacterial genome closure and epitope prediction.

Illumina Launches TruSight™ Targeted Sequencing Content Sets
Friday, February 01, 2013
Expert-designed content enables labs to realize benefits of next-generation sequencing.

<<	1 2 3 4 5 6 7	>>
Showing Results 11 - 20 of 110

Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.

FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.

Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.